# Fluorescence Targeted Pelvic Lymph Node Mapping

> **NCT03204994** · PHASE1,PHASE2 · TERMINATED · sponsor: **Oxford University Hospitals NHS Trust** · enrollment: 1 (actual)

## Conditions studied

- Cancer of Rectum
- Lymph Node Disease

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT03204994
- **Lead sponsor:** Oxford University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Not able to recruit
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204994, "Fluorescence Targeted Pelvic Lymph Node Mapping". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03204994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*